Evidence map›Paper›PMID 29559584›Full record

ArticleScience signaling2018

Gain-of-function mutations in the gene encoding the tyrosine phosphatase SHP2 induce hydrocephalus in a catalytically dependent manner.

Hong Zheng, Wen-Mei Yu, Ronald R Waclaw, Maria I Kontaridis, Benjamin G Neel, Cheng-Kui Qu

Open access · bronzeAbstract read
In one paragraph

Article in Science signaling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Largely preserved vestibular function despite severe-to-profound hearing loss in Noonan syndrome spectrum disorders.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Journal of medical genetics · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Hong ZhengAflac Cancer and Blood Disorders Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA 30322, USA.ORCID 0000-0002-4048-6530
Wen-Mei YuAflac Cancer and Blood Disorders Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA 30322, USA.
Ronald R WaclawDivisions of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.ORCID 0000-0003-4204-4370
Maria I KontaridisDepartment of Medicine, Division of Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-6121-0533
Benjamin G NeelLaura and Isaac Perlmutter Cancer Center, New York University, New York, NY 10016, USA.ORCID 0000-0002-9589-585X
Cheng-Kui QuAflac Cancer and Blood Disorders Center, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA 30322, USA. cheng-kui.qu@emory.edu.ORCID 0000-0002-4256-8652
Children's Healthcare of Atlanta · USBeth Israel Deaconess Medical Center · USCincinnati Children's Hospital Medical Center · USNew York University · US

Funding

Germline mutations of PTPN11 (SHP2) in the stem cell microenvironmentR01HL130995 · NHLBI · EMORY UNIVERSITY · PI QU, CHENG-KUI · 2016 to 2024
$3.3M
Tyrosine Phosphatases and Hematopoietic Cell RegulationR01HL068212 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI QU, CHENG-KUI · 2002 to 2012
$3.2M
Metabolic regulation of hematopoietic stem cellsR01DK092722 · NIDDK · EMORY UNIVERSITY · PI QU, CHENG-KUI · 2011 to 2019
$2.5M
Signaling pathways regulating oligodendrocyte development and functionR01NS088529 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI WACLAW, RONALD R · 2015 to 2019
$1.8M
Elucidating the Phosphatase-Independent Roles of PTPN11 in the HeartR01HL114775 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KONTARIDIS, MARIA I · 2013 to 2016
$1.7M
Targeting SHP2 phosphatase for chemoprevention of leukemic progression in Noonan syndromeR21HD087760 · NICHD · EMORY UNIVERSITY · PI QU, CHENG-KUI · 2017 to 2018
$429k
NHLBI NIH HHS R01 HL068212NHLBI NIH HHS R01 HL114775NHLBI NIH HHS R01 HL130995NICHD NIH HHS R21 HD087760NIDDK NIH HHS R01 DK092722NINDS NIH HHS R01 NS088529
6 · The paper itself

Abstract

Catalytically activating mutations in

Indexed as

Gain of Function MutationAnimalsBiocatalysisEpendymaGenetic Predisposition to DiseaseHumansHydrocephalusLEOPARD SyndromeMice, Inbred C57BLMice, KnockoutMice, TransgenicNeural Stem CellsNoonan SyndromeProtein Tyrosine Phosphatase, Non-Receptor Type 11Protein Tyrosine Phosphatase, Non-Receptor Type 11

Identifiers

PMID29559584
PMCPMC5915342
OpenAlexW2791729687

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.